CTRI/2011/07/001890CompletedPhase 4
A Phase IV, monocentric, clinical trial to evaluate and compare the number of nicks and cuts among three different shaving systems on healthy Indian men.
Procter and Gamble0 sites50 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Healthy Indian men
- •Age group of 18 to 45 years
- •Subjects using double razor with bar soap only for shaving in the past 3 months.
- •Subject having healthy facial skin.
- •Subject willing to participate in the study.
- •Subject willing to abide by and comply with the study protocol.
- •Subject willing to give his consent for study participation.
Exclusion Criteria
- •Subject allergic to any shaving gel.
- •Subjects having visible signs of facial irritation, allergy, sunburn, excessive tanning, or blotchy skin color
- •Subject suffering from any facial skin diseases like allergic contact dermatitis, tinea faciei or tinea barbae, folliculitis (face), severe acne, rosacea, facial psoriasis or other cutaneous manifestations which could interfere with the study.
- •Subject participated in any other similar investigation in the past 6 months.
Investigators
Similar Trials
Recruiting
Phase 4
A clinical trial to study the effects of combination drug in patients suffering from Dry Cough associated with sneezing and running nose or throat irritation.CTRI/2022/11/047227Sun Pharma Laboratories Limited
Not yet recruiting
Phase 4
A clinical trial to study the effects of combination drug as substitution therapy in patients suffering from Stable Chronic Heart Failure (CHF) with Systolic Dysfunction or in Patients of Stable Chronic Angina Pectoris.CTRI/2023/01/049086Sun Pharma Laboratories Limited
Active, not recruiting
Phase 1
A phase IV, unicentric, open label clinical trial to evaluate the default mode network in multiple sclerosis patients on Cladribine treatmentMedDRA version: 20.1Level: PTClassification code: 10028245Term: Multiple sclerosis Class: 100000004852Multiple SclerosisCTIS2023-504577-21-00María Luisa Martínez Ginés20
Active, not recruiting
Not Applicable
Study about the high flow and conventional oxigen therapy in patients with severe acute respiratory failure.EUCTR2012-001671-36-ESFundación para la Investigación Biomédica
Active, not recruiting
Phase 1
IMUNOR® preparation in the prevention of COVID-19COVID-19 preventionEUCTR2020-005524-11-CZFakultní nemocnice Ostrava100